| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/03/2013 | WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | WO2013000941A1 Microbiocidal heterocycles |
| 01/03/2013 | WO2013000267A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 01/03/2013 | WO2013000108A1 Azole heterocylic compounds, preparation methods, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2012062905A3 Chromene derivatives and their analoga as wnt pathway antagonists |
| 01/03/2013 | US20130005967 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 01/03/2013 | US20130005965 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/03/2013 | US20130005964 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/03/2013 | US20130005963 Organic photoelectric conversion material and organic thin-film photoelectric conversion device |
| 01/03/2013 | US20130005962 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments |
| 01/03/2013 | US20130005773 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 01/03/2013 | US20130005771 Oxadiazole compounds, their preparation and use |
| 01/03/2013 | US20130005760 Heterocyclic compound having azole group |
| 01/03/2013 | US20130005736 Antiviral agents |
| 01/03/2013 | US20130005735 Organic compounds |
| 01/03/2013 | US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005725 Chemical compounds |
| 01/03/2013 | US20130005719 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005716 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 01/03/2013 | US20130005710 Aminopyridine derivative |
| 01/03/2013 | US20130005706 Fused heterocyclic compounds as ion channel modulators |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005702 Pyrazole derivatives as protein kinase modulators |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130001536 Novel benzoxazolyl carbazole compound and organic light-emitting device including the same |
| 01/03/2013 | US20130001524 Heterocyclic compound and organic light-emitting device comprising the same |
| 01/03/2013 | DE102011106990B3 Verbindungen als Glykogen Synthase Kinase 3 (GSK-3) Inhibitoren für die Behandlung von GSK-3-vermittelten Erkrankungen Compounds as glycogen synthase kinase 3 (GSK-3) inhibitors for the treatment of GSK-3-mediated diseases |
| 01/03/2013 | CA2839655A1 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | CA2838321A1 Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system diseases |
| 01/03/2013 | CA2838314A1 Indoleamine derivatives for the treatment of central nervous system diseases |
| 01/02/2013 | EP2539335A1 Process for the preparation of isoxazoline derivatives |
| 01/02/2013 | EP2539330A1 Dihydrofuran derivatives as insecticidal compounds |
| 01/02/2013 | EP2539327A1 Oxadiazole compounds, their preparation and use |
| 01/02/2013 | EP2539326A1 Bisaryl-bonded aryltriazolones and use thereof |
| 01/02/2013 | CN102858766A Polymorphs of a metabotropic glutamate receptor positive allosteric modulator |
| 01/02/2013 | CN102858765A Pyrazolyl quinazoline kinase inhibitors |
| 01/02/2013 | CN102858746A Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/02/2013 | CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102850339A New neurokinin (NK-1) receptor antagonist crystal form and preparation method thereof |
| 01/02/2013 | CN102850338A Oxdiazole compound containing pyrazole ring, preparation method and applications thereof |
| 01/02/2013 | CN102850337A Multi-azole linked spirorenone compound and preparation method and application thereof |
| 01/02/2013 | CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 01/02/2013 | CN102850334A Derivative compound treating dibenzofuran as core framework, and its application in OLED (organic light emission diode) |
| 01/02/2013 | CN102850322A Heterocyclic compound, organic light-emitting device, and panel display device |
| 01/02/2013 | CN102850321A Aroxylpyrimidine formamide or aroxylpyridine formamide compound and its preparation method, pharmaceutical composition, and application |
| 01/02/2013 | CN102846609A Synthesis method for antihypertensive agent isradipine and preparation of isradipine |
| 01/02/2013 | CN101778844B Dual modulators of 5-ht2a and d3 receptors |
| 01/02/2013 | CN101747321B Indole-3-benzylamine derivative, preparation method and application |
| 01/02/2013 | CN101679403B Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 |
| 01/02/2013 | CN101659659B Pyridine derivative and medical application thereof |
| 01/02/2013 | CN101516856B Heterocyclic bridged biphenyls and their use in oleds |
| 01/02/2013 | CN101273016B 抗菌喹啉衍生物 Antibacterial quinoline derivatives |
| 01/02/2013 | CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/01/2013 | US8344138 Triazinedione derivatives as GABAB receptor modulators |
| 01/01/2013 | US8344137 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/01/2013 | US8344002 Compound having β-secretase inhibitory activity |
| 01/01/2013 | US8343990 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343987 Heterocyclic derivatives |
| 01/01/2013 | US8343982 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 01/01/2013 | US8343980 Quinazoles useful as modulators of ion channels |
| 01/01/2013 | US8343970 PDE10 inhibitors and related compositions and methods |
| 01/01/2013 | US8343969 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| 01/01/2013 | US8343968 Case of renin inhibitors |
| 01/01/2013 | US8343967 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/01/2013 | US8343966 Organic compounds |
| 01/01/2013 | US8343954 Compositions and methods for inhibition of the JAK pathway |
| 01/01/2013 | US8343913 Hsp90, buffering and drug resistance |
| 12/27/2012 | WO2012178015A2 Lrrk2 inhibitors |
| 12/27/2012 | WO2012177896A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | WO2012177852A1 Substituted imidazopyridinyl compounds |
| 12/27/2012 | WO2012177844A2 Substituted imidazopyridinyl-aminopyridine compounds |
| 12/27/2012 | WO2012176123A1 3 - imidazolyl- indoles for the treatment of proliferative diseases |
| 12/27/2012 | WO2012175520A1 Hydroxy substituted isoquinolinone derivatives |
| 12/27/2012 | WO2012145255A3 Diazonamide analogs |
| 12/27/2012 | WO2012136834A9 Pyrimidine derivatives for the treatment of viral infections |
| 12/27/2012 | WO2012135641A3 Aurora kinase inhibitors and methods of making and using thereof |
| 12/27/2012 | WO2012129564A3 Proteasome chymotrypsin-like inhibition using pi-1833 analogs |
| 12/27/2012 | WO2012071509A3 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture |
| 12/27/2012 | US20120330025 Triarylamine Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120330009 Triazole compounds that modulate hsp90 activity |
| 12/27/2012 | US20120329812 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 12/27/2012 | US20120329796 Compounds useful for treating premature aging and in particular progeria |
| 12/27/2012 | US20120329786 Compounds and therapeutic uses thereof |
| 12/27/2012 | US20120329785 Novel kinase inhibitors |
| 12/27/2012 | US20120329784 Compounds and methods |
| 12/27/2012 | US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 12/27/2012 | US20120329775 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
| 12/27/2012 | US20120329772 Amino-tetrazoles analogues and methods of use |
| 12/27/2012 | US20120329743 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
| 12/27/2012 | US20120328570 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120328569 Inhibitors of hepatitis c virus ns5b polymerase |